Literature DB >> 26870538

Crystal structure of ethyl 2,4-di-chloro-quinoline-3-carboxyl-ate.

Alberto Cabrera1, Luis D Miranda2, Héctor Reyes1, Gerardo Aguirre1, Daniel Chávez1.   

Abstract

In the crystal structure of the title compound, C12H9Cl2NO2, the mean planes through the quinoline and carboxyl-ate groups have r.m.s. deviations of 0.006 and 0.021 Å, respectively, and form a dihedral angle of 87.06 (19)°. In the crystal, mol-ecules are linked via very weak C-H⋯O hydrogen bonds, forming chains, which propagate along the c-axis direction.

Entities:  

Keywords:  crystal structure; human immunodeficiency virus (HIV); hydrogen bonding; quinnoline

Year:  2015        PMID: 26870538      PMCID: PMC4719891          DOI: 10.1107/S2056989015020587

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Related literature

For the potential of related compounds in anti-HIV treatment, see: Maartens et al. (2014 ▸); Hopkins et al. (2004 ▸). For a related structure, see: Reyes et al. (2013 ▸)

Experimental

Crystal data

C12H9Cl2NO2 M = 270.10 Monoclinic, a = 8.5860 (4) Å b = 19.9082 (11) Å c = 7.1304 (4) Å β = 100.262 (1)° V = 1199.32 (11) Å3 Z = 4 Mo Kα radiation μ = 0.53 mm−1 T = 298 K 0.50 × 0.25 × 0.16 mm

Data collection

Bruker APEXII CCD area-detector diffractometer 6785 measured reflections 2197 independent reflections 1833 reflections with I > 2σ(I) R int = 0.024

Refinement

R[F 2 > 2σ(F 2)] = 0.035 wR(F 2) = 0.094 S = 1.05 2197 reflections 156 parameters H-atom parameters constrained Δρmax = 0.22 e Å−3 Δρmin = −0.21 e Å−3

Data collection: APEX2 (Bruker, 2012 ▸); cell refinement: SAINT (Bruker, 2012 ▸); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2015 ▸); program(s) used to refine structure: SHELXL2013 (Sheldrick, 2015 ▸); molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL. Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S2056989015020587/nk2231sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015020587/nk2231Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989015020587/nk2231Isup3.cml Click here for additional data file. . DOI: 10.1107/S2056989015020587/nk2231fig1.tif The asymmetric unit of the title compound with displacement ellipsoids drawn at the 50% probability level. Click here for additional data file. . DOI: 10.1107/S2056989015020587/nk2231fig2.tif Crystal packing viewed along the a axis. The inter­molecular C—H⋯O hydrogen bonds are shown as dashed lines. CCDC reference: 1434378 Additional supporting information: crystallographic information; 3D view; checkCIF report
C12H9Cl2NO2F(000) = 552
Mr = 270.10Dx = 1.496 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
a = 8.5860 (4) ÅCell parameters from 4843 reflections
b = 19.9082 (11) Åθ = 2.4–25.4°
c = 7.1304 (4) ŵ = 0.53 mm1
β = 100.262 (1)°T = 298 K
V = 1199.32 (11) Å3Prism, colourless
Z = 40.50 × 0.25 × 0.16 mm
Bruker APEXII CCD area-detector diffractometerRint = 0.024
Detector resolution: 0.83 pixels mm-1θmax = 25.4°, θmin = 2.1°
ω scansh = −10→10
6785 measured reflectionsk = −23→23
2197 independent reflectionsl = −8→8
1833 reflections with I > 2σ(I)
Refinement on F2Hydrogen site location: inferred from neighbouring sites
Least-squares matrix: fullH-atom parameters constrained
R[F2 > 2σ(F2)] = 0.035w = 1/[σ2(Fo2) + (0.052P)2 + 0.1257P] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.094(Δ/σ)max = 0.001
S = 1.05Δρmax = 0.22 e Å3
2197 reflectionsΔρmin = −0.21 e Å3
156 parametersExtinction correction: SHELXL2013 (Sheldrick, 2015), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
0 restraintsExtinction coefficient: 0.010 (2)
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
xyzUiso*/Ueq
Cl10.85142 (7)0.95554 (3)0.67524 (10)0.0847 (2)
Cl20.49224 (5)0.73357 (2)0.59388 (7)0.05637 (19)
O10.48324 (17)0.90370 (7)0.44065 (18)0.0701 (4)
O20.48524 (14)0.89699 (6)0.75480 (17)0.0565 (3)
N10.96891 (17)0.83536 (9)0.7101 (2)0.0567 (4)
C20.8376 (2)0.86809 (9)0.6757 (2)0.0514 (4)
C30.68405 (18)0.84036 (8)0.6379 (2)0.0435 (4)
C40.67539 (18)0.77181 (8)0.6378 (2)0.0415 (4)
C50.8137 (3)0.66071 (10)0.6754 (3)0.0621 (5)
H50.71870.63720.65050.075*
C60.9535 (3)0.62696 (13)0.7135 (3)0.0816 (7)
H60.95310.58020.71430.098*
C71.0976 (3)0.66121 (14)0.7514 (3)0.0838 (8)
H71.19180.63710.77790.101*
C81.1014 (2)0.72928 (13)0.7498 (3)0.0705 (6)
H81.19810.75160.77480.085*
C90.9593 (2)0.76660 (10)0.7105 (2)0.0511 (5)
C100.81366 (19)0.73162 (9)0.6738 (2)0.0451 (4)
C110.5396 (2)0.88399 (9)0.5963 (2)0.0478 (4)
C120.3434 (2)0.93853 (11)0.7367 (3)0.0674 (5)
H12A0.25750.91820.64810.081*
H12B0.36380.98280.68970.081*
C130.3010 (3)0.94358 (13)0.9279 (3)0.0858 (7)
H13A0.27210.90000.96810.129*
H13B0.21330.97380.92350.129*
H13C0.39000.96021.01660.129*
U11U22U33U12U13U23
Cl10.0773 (4)0.0613 (3)0.1107 (5)−0.0197 (3)0.0034 (3)−0.0015 (3)
Cl20.0445 (3)0.0641 (3)0.0597 (3)−0.01024 (19)0.0070 (2)−0.0018 (2)
O10.0713 (9)0.0848 (10)0.0506 (8)0.0213 (7)0.0009 (7)0.0096 (7)
O20.0498 (7)0.0681 (8)0.0529 (7)0.0183 (6)0.0129 (6)0.0081 (6)
N10.0395 (8)0.0795 (11)0.0508 (9)−0.0050 (7)0.0070 (6)−0.0022 (8)
C20.0455 (10)0.0606 (11)0.0475 (10)−0.0066 (8)0.0064 (8)−0.0016 (8)
C30.0393 (9)0.0544 (10)0.0367 (8)0.0011 (7)0.0069 (7)0.0000 (7)
C40.0377 (8)0.0548 (10)0.0325 (8)−0.0016 (7)0.0073 (6)−0.0002 (7)
C50.0719 (13)0.0630 (12)0.0520 (11)0.0133 (10)0.0128 (9)0.0027 (9)
C60.0980 (19)0.0785 (15)0.0680 (14)0.0429 (14)0.0143 (13)0.0066 (11)
C70.0768 (16)0.118 (2)0.0564 (13)0.0554 (16)0.0110 (11)0.0060 (13)
C80.0445 (11)0.120 (2)0.0476 (11)0.0239 (11)0.0085 (8)−0.0009 (11)
C90.0412 (9)0.0793 (13)0.0337 (9)0.0101 (8)0.0090 (7)−0.0001 (8)
C100.0451 (9)0.0608 (11)0.0301 (8)0.0100 (8)0.0088 (7)0.0016 (7)
C110.0440 (9)0.0499 (9)0.0481 (10)−0.0006 (7)0.0042 (8)0.0018 (8)
C120.0544 (11)0.0706 (12)0.0778 (13)0.0229 (10)0.0136 (10)0.0079 (11)
C130.0641 (14)0.1089 (19)0.0878 (16)0.0215 (13)0.0227 (12)−0.0130 (14)
Cl1—C21.745 (2)C6—C71.396 (4)
Cl2—C41.7248 (16)C6—H60.9300
O1—C111.195 (2)C7—C81.356 (4)
O2—C111.323 (2)C7—H70.9300
O2—C121.459 (2)C8—C91.413 (3)
N1—C21.287 (2)C8—H80.9300
N1—C91.371 (3)C9—C101.414 (2)
C2—C31.411 (2)C12—C131.476 (3)
C3—C41.367 (2)C12—H12A0.9700
C3—C111.500 (2)C12—H12B0.9700
C4—C101.417 (2)C13—H13A0.9600
C5—C61.360 (3)C13—H13B0.9600
C5—C101.412 (3)C13—H13C0.9600
C5—H50.9300
C11—O2—C12116.84 (14)C9—C8—H8119.8
C2—N1—C9117.06 (15)N1—C9—C8118.38 (18)
N1—C2—C3126.55 (18)N1—C9—C10122.85 (15)
N1—C2—Cl1116.62 (14)C8—C9—C10118.77 (19)
C3—C2—Cl1116.83 (14)C5—C10—C9119.45 (16)
C4—C3—C2116.09 (15)C5—C10—C4124.43 (17)
C4—C3—C11122.35 (14)C9—C10—C4116.12 (16)
C2—C3—C11121.55 (15)O1—C11—O2125.64 (16)
C3—C4—C10121.33 (15)O1—C11—C3123.90 (16)
C3—C4—Cl2119.25 (12)O2—C11—C3110.46 (14)
C10—C4—Cl2119.42 (13)O2—C12—C13107.24 (16)
C6—C5—C10119.7 (2)O2—C12—H12A110.3
C6—C5—H5120.2C13—C12—H12A110.3
C10—C5—H5120.2O2—C12—H12B110.3
C5—C6—C7121.2 (2)C13—C12—H12B110.3
C5—C6—H6119.4H12A—C12—H12B108.5
C7—C6—H6119.4C12—C13—H13A109.5
C8—C7—C6120.5 (2)C12—C13—H13B109.5
C8—C7—H7119.7H13A—C13—H13B109.5
C6—C7—H7119.7C12—C13—H13C109.5
C7—C8—C9120.4 (2)H13A—C13—H13C109.5
C7—C8—H8119.8H13B—C13—H13C109.5
D—H···AD—HH···AD···AD—H···A
C7—H7···O1i0.932.693.586 (3)162
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
C7—H7⋯O1i 0.932.693.586 (3)162

Symmetry code: (i) .

  4 in total

1.  Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.

Authors:  Andrew L Hopkins; Jingshan Ren; John Milton; Richard J Hazen; Joseph H Chan; David I Stuart; David K Stammers
Journal:  J Med Chem       Date:  2004-11-18       Impact factor: 7.446

Review 2.  HIV infection: epidemiology, pathogenesis, treatment, and prevention.

Authors:  Gary Maartens; Connie Celum; Sharon R Lewin
Journal:  Lancet       Date:  2014-06-05       Impact factor: 79.321

3.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

4.  4-Hy-droxy-6-methyl-pyridin-2(1H)-one.

Authors:  Héctor Reyes; Gerardo Aguirre; Daniel Chávez
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.